N12 Technologies to Showcase its Patented Z-axis Mechanical Enhancement Technology at CAMX in Dallas

N12 Technologies, Inc., a Cambridge, MA-based nanotechnology company, has commercialized an MIT-developed technology to become the world's first manufacturer capable of industrialized, continuous Vertically Aligned Carbon Nano Tube (VACNT) production. The Company will showcase its patented Z-axis mechanical enhancement technology at CAMX in Dallas on October 27-29th, 2015.

SEM picture of Nanostitch™ Technology

This award-winning Company's revolutionary product, NanoStitch™, significantly increases inter-laminar strength by changing the shear, fracture, compression, and fatigue performance of composite materials. As a fast growing, well capitalized company, N12 is scaling manufacturing capacity, testing materials for multiple OEM programs, and collaborating with the world's leading prepreg composite suppliers to develop a full range of certified NanoStitch™-enhanced fibre/resin systems. The Company is also developing NanoStitch™-enhanced products compatible with resin infusion techniques, thermoplastics and adhesives. "NanoStitch™ is a unique enabler that broadens what can be made with composite material," said N12 CEO Brad Berkson.

He also acknowledges the importance of this first industry event. "We already have over 100 OEMs globally exploring and testing our technology and have now committed the capital through 2018 and beyond to build industrial-scale NanoStitch™ manufacturing capacity. CAMX is an important US platform to demonstrate N12's technology and capabilities to its audience of industry leaders," said Brad. "'Making the Best, Better,' is what NanoStitch™ and N12 is all about."

The Company can be found at booth S-123 in the CAMX Exposition Hall.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.